Crawford & Company Common Stock has a consensus price target of $11, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Truist Securities on August 7, 2023. With an average price target of $11 between Truist Securities, there's an implied 24.43% upside for Crawford & Company Common Stock from these 1 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Crawford & Company Common Stock (NYSE: CRD/B) was reported by Truist Securities on August 7, 2023. The analyst firm set a price target for $11.00 expecting CRD/B to rise to within 12 months (a possible 24.43% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Crawford & Company Common Stock (NYSE: CRD/B) was provided by Truist Securities, and Crawford & Company Common Stock maintained their buy rating.
There is no last upgrade for Crawford & Company Common Stock.
There is no last downgrade for Crawford & Company Common Stock.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crawford & Company Common Stock, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crawford & Company Common Stock was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
While ratings are subjective and will change, the latest Crawford & Company Common Stock (CRD/B) rating was a maintained with a price target of $10.00 to $11.00. The current price Crawford & Company Common Stock (CRD/B) is trading at is $8.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.